Immunoprecise Enterprise Value vs Free Cash Flow Analysis

IPA -  USA Stock  

USD 4.14  0.15  3.50%

Immunoprecise Antibodies financial indicator trend analysis is infinitely more than just investigating Immunoprecise Antibodies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunoprecise Antibodies is a good investment. Please check the relationship between Immunoprecise Antibodies Enterprise Value and its Free Cash Flow accounts. Please see Risk vs Return Analysis.

Enterprise Value vs Free Cash Flow

Enterprise Value vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunoprecise Antibodies Enterprise Value account and Free Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Immunoprecise Antibodies' Enterprise Value and Free Cash Flow is -0.51. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Immunoprecise Antibodies, assuming nothing else is changed. The correlation between historical values of Immunoprecise Antibodies' Enterprise Value and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of Immunoprecise Antibodies are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Enterprise Value i.e., Immunoprecise Antibodies' Enterprise Value and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.51
Relationship DirectionNegative 
Relationship StrengthVery Weak

Enterprise Value

Enterprise Value (or EV) is usually referred to as Immunoprecise Antibodies theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Immunoprecise Antibodies debt, but would also pocket its cash. Enterprise Value is more accurate representation of Immunoprecise Antibodies value than its market capitalization because it takes into account all of Immunoprecise Antibodies existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Free Cash Flow

Free Cash Flow is a measure of financial performance calculated as Net Cash Flow from Operations minus Capital Expenditure.
Most indicators from Immunoprecise Antibodies fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunoprecise Antibodies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Risk vs Return Analysis.The current year Issuance Purchase of Equity Shares is expected to grow to about 54.8 M, whereas Selling General and Administrative Expense is forecasted to decline to about 8.7 M.
 2019 2020 2021 2022 (projected)
Interest Expense537 K517 K594.55 K596.14 K
Gross Profit8.03 M11.54 M13.27 M11.78 M

Immunoprecise Antibodies fundamental ratios Correlations

0.98-0.960.980.58-0.990.920.651.0-0.960.990.820.82-0.7-0.960.821.00.930.851.0-0.55
0.98-0.971.00.62-1.00.90.680.98-0.960.990.840.84-0.7-0.950.840.980.930.850.98-0.59
-0.96-0.97-0.97-0.70.96-0.91-0.73-0.950.97-0.99-0.9-0.90.680.92-0.89-0.98-0.94-0.89-0.960.68
0.981.0-0.970.6-1.00.890.650.98-0.950.990.820.82-0.72-0.960.820.980.920.840.98-0.56
0.580.62-0.70.6-0.60.840.990.55-0.780.640.940.940.04-0.380.940.660.830.920.6-1.0
-0.99-1.00.96-1.0-0.6-0.91-0.66-0.990.96-0.99-0.82-0.820.690.95-0.82-0.99-0.93-0.85-0.990.56
0.920.9-0.910.890.84-0.910.90.9-0.990.930.950.95-0.37-0.770.960.951.00.980.92-0.82
0.650.68-0.730.650.99-0.660.90.63-0.840.70.960.960.0-0.440.960.720.880.960.67-0.98
1.00.98-0.950.980.55-0.990.90.63-0.950.990.790.79-0.72-0.960.790.990.920.831.0-0.52
-0.96-0.960.97-0.95-0.780.96-0.99-0.84-0.95-0.97-0.94-0.940.520.86-0.94-0.98-0.99-0.96-0.970.76
0.990.99-0.990.990.64-0.990.930.70.99-0.970.860.86-0.69-0.950.861.00.950.870.99-0.61
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
0.820.84-0.90.820.94-0.820.950.960.79-0.940.861.0-0.29-0.661.00.870.960.990.82-0.93
-0.7-0.70.68-0.720.040.69-0.370.0-0.720.52-0.69-0.29-0.290.88-0.28-0.65-0.43-0.27-0.69-0.06
-0.96-0.950.92-0.96-0.380.95-0.77-0.44-0.960.86-0.95-0.66-0.660.88-0.66-0.93-0.8-0.68-0.950.35
0.820.84-0.890.820.94-0.820.960.960.79-0.940.861.01.0-0.28-0.660.870.960.990.83-0.93
1.00.98-0.980.980.66-0.990.950.720.99-0.981.00.870.87-0.65-0.930.870.960.891.0-0.63
0.930.93-0.940.920.83-0.931.00.880.92-0.990.950.960.96-0.43-0.80.960.960.980.94-0.81
0.850.85-0.890.840.92-0.850.980.960.83-0.960.870.990.99-0.27-0.680.990.890.980.86-0.9
1.00.98-0.960.980.6-0.990.920.671.0-0.970.990.820.82-0.69-0.950.831.00.940.86-0.57
-0.55-0.590.68-0.56-1.00.56-0.82-0.98-0.520.76-0.61-0.93-0.93-0.060.35-0.93-0.63-0.81-0.9-0.57
Click cells to compare fundamentals

Immunoprecise Antibodies Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Immunoprecise Antibodies without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immunoprecise Antibodies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
101.5 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.